I now have solid information from authoritative surgical and pharmacology textbooks. Here is the full answer:
Tranexamic Acid (TXA) and Vitamin K in RTA/Trauma Bleeding
You are asking about two hemostatic agents commonly used in road traffic accident (RTA) patients with significant hemorrhage. Here is a clear clinical breakdown of each.
Tranexamic Acid (TXA) - "Tenexamycin" / "Tranexam"
What it is: TXA is an antifibrinolytic drug. It does NOT form a blood clot directly - instead, it prevents clot breakdown (fibrinolysis) by blocking plasminogen from converting to plasmin. This keeps whatever clot the body has already formed intact, reducing ongoing blood loss.
Mechanism:
- Plasmin normally dissolves fibrin clots
- TXA competitively inhibits plasminogen binding to fibrin
- Result: existing clots are preserved, hemorrhage is reduced
Dose in Trauma (CRASH-2 protocol - the landmark RCT):
| Step | Dose | Route | Rate |
|---|
| Loading dose | 1 g | IV | Over 10 minutes |
| Maintenance | 1 g | IV | Over 8 hours |
Critical timing rule:
- Give as early as possible after injury - ideally within 1 hour
- Do NOT give after 3 hours from injury - studies show it may increase bleeding mortality if given late
- It should be given to any trauma patient with:
- Systolic BP < 110 mmHg, OR
- Heart rate > 110/min, OR
- Clinically suspected significant hemorrhage
Evidence base: The CRASH-2 trial (32,000+ patients) showed TXA reduces mortality from bleeding in both blunt and penetrating trauma. The benefit was greatest when given within the first hour.
(Bailey & Love's Short Practice of Surgery 28th Ed.; Goodman & Gilman's Pharmacological Basis of Therapeutics)
Vitamin K in Trauma Bleeding
What it is: Vitamin K is a fat-soluble cofactor required for the synthesis and activation of coagulation factors II (Thrombin), VII, IX, and X (the "PIVKA" factors - proteins induced by Vitamin K absence). Without Vitamin K, these factors are inactive and cannot form clots.
When to use in RTA patients:
- If the patient is on warfarin (anticoagulant) and needs reversal
- If there is known or suspected Vitamin K deficiency (malnutrition, liver disease, prolonged antibiotics)
- Elevated INR/PT on labs suggesting coagulation factor deficiency
Dose:
- 10 mg IV is the standard dose for reversal of warfarin or Vitamin K deficiency
- Onset: 6-10 hours to reverse Vitamin K-dependent factors
- This means Vitamin K alone is too slow for an actively bleeding trauma patient - Fresh Frozen Plasma (FFP) or Prothrombin Complex Concentrate (PCC) is needed immediately alongside it for urgent reversal
Important limitation: In patients with severe liver failure, Vitamin K will NOT work because the liver cannot manufacture the coagulation factors even when Vitamin K is present.
(Rosen's Emergency Medicine; Harrison's Principles of Internal Medicine 22nd Ed.)
Key Differences: TXA vs Vitamin K in RTA
| Feature | Tranexamic Acid (TXA) | Vitamin K |
|---|
| Mechanism | Prevents clot breakdown (antifibrinolytic) | Enables clot factor synthesis |
| Onset | Rapid (minutes) | Slow (6-10 hours) |
| Used in | ALL significant trauma bleeding | Warfarin reversal / Vit K deficiency |
| Dose | 1g IV over 10 min + 1g over 8 hrs | 10 mg IV |
| Timing critical? | YES - must give within 3 hrs of injury | No (used when indicated) |
| Emergency trauma use | First-line, universal | Second-line, selected patients |
Summary for RTA Patient with High Bleeding
- Give TXA immediately (within 1 hour, never after 3 hours) - 1g IV over 10 min, then 1g over 8 hrs
- Vitamin K is given if the patient has warfarin on board or proven coagulopathy from Vitamin K deficiency - but expect a 6-10 hour delay in effect
- For active, life-threatening bleeding, also consider: blood transfusion, FFP, platelets, and surgical hemorrhage control
- Always do a whole-body CT scan (WBCT) to identify sources of hemorrhage
Clinical Note: These two drugs work by completely different mechanisms and are not interchangeable. TXA is the primary drug for ALL bleeding trauma patients. Vitamin K is a targeted treatment for specific coagulopathies.